Structure Therapeutics Inc. (GPCR)

NASDAQ: GPCR · Real-Time Price · USD

39.55

-1.68 (-4.07%)

At close: Sep 10, 2026, 4:00 PM EDT

40.00

+0.45 (1.14%)

Pre-market: Sep 11, 2026, 7:25 AM EDT

Structure Therapeutics Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Income	-268.06	-186.81	-158.23	-102.78	-52.56	-37.7
Net Income	-214.84	-141.2	-122.53	-89.62	-52.84	-43.77
Earnings Per Share	-3.22	-2.39	-2.33	-2.44	-16.54	-16.13
EPS Growth	-	-	-	-	-	-

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	1,343	1,446	883.52	467.32	90.84	107.31
Total Debt	6.23	6.49	3.86	5.45	0.26	0.62
Net Cash (Debt)	1,336	1,440	879.66	461.87	90.58	106.69
Net Cash Growth	71.60%	63.67%	90.45%	409.90%	-15.10%	187.06%
Net Cash Per Share	20.02	24.32	16.71	12.57	28.35	39.31

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-220.29	-222.2	-116.64	-79.49	-46.12	-32.16
Capital Expenditures	-4.21	-3.61	-1.29	-2.17	-0.16	-1.21
Free Cash Flow	-224.5	-225.81	-117.93	-81.66	-46.28	-33.37
Free Cash Flow Growth	-	-	-	-	-	-

Selected indicators aren't available for this stock.